Use of Intravitreal Triamcinolone in the Treatment of Macular Edema Related to Retinal Vein Occlusion
Ashish Sharma, Baruch D.Kuppermann, M. Cristina Kenney*
Department of Ophthalmology, School of Medicine, University of California, Irvine, USA
Objective: To analyze the increasing trend of intravitreal triamcinolone (IVTA) use in the treatment of retinal vein occlusion-related macular edema.
Methods:We performed MEDLINE/PUBMED searches (September 1984 - December 2007) to identify articles containing the keywords macular edema and triamcinolone. Case reports, reviews and abstracts were identified from references in the reviewed literature. This review focuses on literature published during the past 7 years with more than two-thirds of the articles that we reviewed being printed during the past 5 years. These reports analyzed the success of IVTA in the treatment of macular edema over a 12 month course of time.
Results: The majority of studies suggested promising results for short time periods (4-6 months) after IVTA treatments. However, long term results were not encouraging.
Conclusions: The success of IVTA therapy for short durations has been the impetus for development of sustained release devices to be used in the treatment of macular edema associated with various retinal diseases including edema related to retinal vein occlusion.
Received Date: 1/2/2008 Revision Received Date: 27/2/2008 Acceptance Date: 13/3/2008 Electronic publication date: 7/4/2008 Collection year: 2008
Full-Text HTML Views: 999 Abstract HTML Views: 644 PDF Downloads: 180 Total Views/Downloads: 1823
Full-Text HTML Views: 478 Abstract HTML Views: 439 PDF Downloads: 131 Total Views/Downloads: 1048 Geographical View
2008 Bentham Science Publishers Ltd
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/), which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.
* Address correspondence to this author at the Department of Ophthalmology, School of Medicine, University of California, Irvine, USA;E-mail: firstname.lastname@example.org